Psygen logo — A Dedicated Psychedelic GMP Manufacturer

Psygen

A Dedicated Psychedelic GMP Manufacturer

Founded 2018 Canada Calgary, Canada 22 employees Venture round Total: $5.50M Biotechnology, Manufacturing

General Information

Company Name Psygen
Founded Year 2018
Location Canada Calgary, Canada
Founders / Decision Makers
Team member
Employees 22
Industries Biotechnology, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Psygen. To contact Psygen, visit psygen.ca.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Psygen compare?

A PDF of Psygen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Psygen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Psygen

Psygen is a biotechnology and manufacturing startup founded in 2019 and based in Canada. The company's slogan, "A Dedicated Psychedelic GMP Manufacturer," underscores its primary focus on providing a pharmaceutical-grade psychedelic supply chain solution for clinicians and researchers. Psygen boasts the world's first dedicated, GMP compliant, state-of-the-art, large-scale manufacturing facility, positioning itself as a leader in this niche market. Their most recent investment, a Venture Round investment at 01 January 2022, came from Noetic Fund. This strategic investment signifies confidence in Psygen's innovative approach and potential for growth within the burgeoning psychedelic medicine industry.

Business keywords: Psychedelic drugs, GMP compliant, Pharmaceutical-grade, Manufacturing facility, Clinical research, Therapeutic applications, Supply chain solution, Large-scale manufacturing, Pharmaceutical products, Psygen, Psychedelic GMP manufacturer

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Noetic Fund
01 Jan 2022
Debt Financing $5.50M -
05 Aug 2021

Psygen Alternatives & Competitors

View All Alternatives
Psygen vs
GESLabs
GESLabs United Kingdom

Leading Naturally

41 employees
Biotechnology, Health and Wellness
Psygen vs
Lompostran
Lompostran Portugal

We pair our expertise with your vision to bring your products to the market.

3 employees
Analytics, Biotechnology
Psygen vs
Flamma
Flamma Italy

Family owned & run. Advancing amino acids & small molecules since 1950. See why FLAMMA is The Thinki...

452 employees
Biotechnology, Manufacturing

FAQ About Psygen

A Dedicated Psychedelic GMP Manufacturer
Psygen was founded in 2018.
Psygen is headquartered in Calgary, Canada.
Psygen operates in Biotechnology and Manufacturing. Its work centres on Psychedelic drugs, GMP compliant, Pharmaceutical-grade and Manufacturing facility.
Psygen has approximately 22 employees.
Psygen has completed 2 funding rounds, raising a total of $5.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Psygen include GESLabs, Lompostran, Flamma, Burrard Pharmaceuticals, Baccinex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Psygen and GESLabs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Psygen, https://bouncewatch.com/company/psygen, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes